# Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation

> **NCT00631813** · PHASE2 · COMPLETED · sponsor: **Movetis** · enrollment: 253 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** Prucalopride
- **DRUG:** Prucalopride
- **DRUG:** Prucalopride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00631813
- **Lead sponsor:** Movetis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-11
- **Primary completion:** 1997-04
- **Final completion:** 1997-04
- **Target enrollment:** 253 (ACTUAL)
- **Last updated:** 2008-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00631813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00631813, "Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00631813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*